Trade Mark Journal No.2025/027 4 July 2025

WO0000001860110 (42,44,45)

Office of origin: Germany

Date of International Registration:19 March 2025
Date of designation in the UK: 19 March 2025
Image for mark 1860110

The mark contains the colours blue, green and white.

International priority date claimed: 20 September 2024 (Germany)
Class 42
Scientific research services in the field of biochemistry [excluding the field of cell culture products], nucleic acids and bioinformatics, in particular molecular biology techniques, especially antisense techniques; design of pharmaceutical active ingredients by means of the aforementioned processes and techniques, including the use of bioinformatics techniques; development of pharmaceutical products by means of the aforementioned processes and techniques, including the use of bioinformatics techniques, including the performance of associated testing and diagnostic procedures; bioinformatic services for the pharmaceutical and biotechnological industry; services for evaluating the efficacy and safety of pharmaceutical products.
Class 44
Consultancy services to third parties in the field of biochemistry and nucleic acids and bioinformatics, including antisense technology, in relation to the development of pharmaceutical products; consultancy services to third parties in relation to the evaluation of safety and efficacy of pharmaceuticals.
Class 45
Licensing of industrial property rights arising from scientific research services in the field of biochemistry [excluding the field of cell culture products], nucleic acids and bioinformatics, in particular molecular biology techniques, especially antisense techniques; licensing of industrial property rights arising from the design of pharmaceutical active ingredients by means of the aforementioned processes and techniques, including the use of bioinformatics techniques; licensing of industrial property rights arising from the development of pharmaceutical products by means of the aforementioned processes and techniques, including the use of bioinformatics techniques, including the performance of associated testing and diagnostic procedures; licensing of industrial property rights arising from bioinformatic services for the pharmaceutical and biotechnological industry; licensing of industrial property rights arising from the services for evaluating the efficacy and safety of pharmaceutical products.

Secarna Pharmaceuticals GmbH & Co. KG

Representative: LORENZ SEIDLER GOSSEL Rechtsanwälte Patentanwälte, Widenmayerstr. 23, 80538 München, GERMANY